Scheme Profile

HDFC Pharma and Healthcare Fund - Regular (G)

Get detailed information of scheme on investment, NAV, Performance.
AUM ( Cr. )
1,977
Inception Date
04-10-2023
Category
Equity - Sectoral - Pharma

Key Parameters

  • Type
  • OPEN ENDED
  • Minimum Investment ()
  • 100
  • 52 Week High / Low ()
  • 17.911 (26-Feb-2026) / 15.686 (09-May-2025)
  • Incremental Investment ()
  • 100
  • NAV ()
  • 17.81 ( 0.07) ( 0.39 %)
  • Benchmark
  • BSE Healthcare TRI
  • Fund Manager
  • Nikhil Mathur
  • Value of () 1,00,000 since inception
  • 1,78,120
  • Entry Load
  • Nil
  • Exit Load
  • In respect of each purchase/Switch-in of units, an Exit load of 1% is payable if units are redeemed/switched-out within 30 days from the date of allotment. No Exit Load is payable if units are redeemed / switched-out after 30 days from the date of allotment.
  • Expense Ratio (%)
  • 2.10
  • Maturity Date
  • NA

Portfolio Indicators

  • Portfolio P/E
  • 54.19 times
  • Portfolio P/B
  • 8.21 times
  • Average Maturity
  • -
  • Yield To Maturity
  • -
  • Modified Duration
  • -
  • Turnover Ratio (%)
  • 37.97

Risk Factors

  • Jenson's Alpha
  • 17.86
  • Standard Deviation
  • 4.88
  • Beta
  • 0.69
  • Sharpe
  • 1.01
  • R-Squared
  • 1.00
  • Treynor Factor
  • 0.03

NAV Movement

AUM Growth ( Cr.)

Performance

  • Scheme Name
  • YTD (%)
  • 3 Months (%)
  • 6 Months (%)
  • 1 Year (%)
  • 3 Years (%)
  • 5 Years (%)
  • 10 Years (%)
  • Since Inception
  • BSE Healthcare TRI
  • 10.35
  • -0.51
  • 15.09
  • 48.32
  • 13.19
  • 22.14
  • 13.77
  • -

Company Top 5 Holdings

  [ As on 31 Mar 2026 ] More
  • Company
  • Asset
  • Value( in Cr.)
  • Holdings (%)
  • Sun Pharmaceutical Industries Ltd
  • Equity
  • 11,47,049
  • 10.20
  • Divis Laboratories Ltd
  • Equity
  • 2,72,646
  • 8.20
  • Glenmark Pharmaceuticals Ltd
  • Equity
  • 6,28,837
  • 6.78
  • Lupin Ltd
  • Equity
  • 5,68,274
  • 6.65
  • Alkem Laboratories Ltd
  • Equity
  • 2,23,494
  • 5.99

Sector Top 5 Holdings

  [ As on 31 Mar 2026 ] More
  • Sector
  • Value( in Cr.)
  • Holdings (%)
  • Pharmaceuticals
  • 92,27,872
  • 71.61
  • Healthcare
  • 83,12,209
  • 28.39

Annual Performance

Year Return (%) AUM ( in Cr.)
Scheme Return Category Return Benchmark Return Sensex Return
YTD 3.68 -0.03 - -7.86 1,976.86
2025 0.84 -4.35 - 8.55 1,983.91
2024 49.92 34.92 10.35 8.12 1,577.12
2023 13.24 31.12 38.35 18.10 648.29

Quarterly Performance

Year Return (%) AUM ( in Cr.)
Scheme Return Category Return Benchmark Return Sensex Return
Mar-2026 -1.18 -3.91 - 0 1,976.86
Dec-2025 1.68 0.18 - 0 1,983.91
Sep-2025 -0.37 -2.02 - 0 1,896.11
Jun-2025 7.55 7.66 - 0 1,786.18

Peer Comparison

<< < 12> >> 

Asset Allocation

Sector Allocation

Close